Genmab is a biotechnology company based in Copenhagen, Denmark, that develops antibody-based medicines for the treatment of cancer and other serious diseases. Its work centres on engineered antibodies designed to help the immune system attack cancer cells, and it advances these candidates through clinical development. The company works with pharmaceutical partners on late-stage programmes and also markets some of its medicines itself, serving patients through oncology treatment centres and specialist physicians.
The shares are listed on the London Exchange in UK under the code 0MGB, and the price on this page is in Danish kroner (DKK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #141 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
95/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average37.4%
From 52-week high0.0%
MomentumStrong
85/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return38.9%
6-month return49.4%
12-month, skipping last month17.8%
Stability (higher is calmer)Weak
49/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)33.4%
Worst drawdown, 1 year (smaller is calmer)-32.3%
LiquidityStrong
81/100
Trades actively.
See the numbers →
Avg daily value traded28.92M DKK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 1,514.50 – 2,652.00Daily closes, split-adjusted
Signals
50-day average2,276.69
200-day average1,930.01
Golden/death cross (60d)Golden, 43 days ago
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)83.69
Technical summary
Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
2,533.2
Bullish
EMA 10
2,540.6
Bullish
SMA 20
2,443.6
Bullish
EMA 20
2,460.2
Bullish
SMA 50
2,276.7
Bullish
EMA 50
2,293.4
Bullish
SMA 100
2,037.8
Bullish
EMA 100
2,133.1
Bullish
SMA 200
1,930.0
Bullish
EMA 200
1,993.1
Bullish
Oscillators (daily)
RSI (14)
72.58
Bearish
MACD (12, 26)
102.2
Bullish
Momentum (12)
6.85
Bullish
Stochastic %K (14)
100.0
Bearish
Williams %R (14)
0.00
Bearish
CCI (20)
141.9
Bearish
Pivot points (classic, last session)
S3
2,527.0
S2
2,552.0
S1
2,602.0
Pivot
2,627.0
R1
2,677.0
R2
2,702.0
R3
2,752.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in DKK. Educational only, not financial advice.
